See more : Aucfan Co., Ltd. (3674.T) Income Statement Analysis – Financial Results
Complete financial analysis of Adiuvo Investments S.A. (ADV.WA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Adiuvo Investments S.A., a leading company in the Medical – Devices industry within the Healthcare sector.
- Carmila S.A. (CARM.PA) Income Statement Analysis – Financial Results
- Sreechem Resins Limited (SRECR.BO) Income Statement Analysis – Financial Results
- NexTech AR Solutions Corp. (NTAR.CN) Income Statement Analysis – Financial Results
- V2X, Inc. (VEC) Income Statement Analysis – Financial Results
- Keymed Biosciences Inc. (2162.HK) Income Statement Analysis – Financial Results
Adiuvo Investments S.A. (ADV.WA)
About Adiuvo Investments S.A.
Adiuvo Investments S.A. is a venture capital firm specializing in incubation, seed, startup, early venture, and growth capital investments. The firm primarily invests in projects in the segment of medical devices, digital health, and nutraceuticals. It seeks to invest in Poland. The firm typically invests up to a maximum of €3 million ($3.35 million). It prefers to hold its investments from three up to five years. The firm makes balance sheet investments. Adiuvo Investment S.A. was founded in 2013 and is based in Warsaw, Poland.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 990.00K | 449.00K | 1.60M | 942.00K | 1.78M | 2.79M | 5.76M | 4.78M | 3.94M | 36.00K | 0.00 |
Cost of Revenue | 7.00K | 269.00K | 939.00K | 291.00K | 645.00K | 1.42M | 3.39M | 3.47M | 2.55M | 2.79M | 16.00K |
Gross Profit | 983.00K | 180.00K | 665.00K | 651.00K | 1.13M | 1.38M | 2.37M | 1.31M | 1.39M | -2.76M | -16.00K |
Gross Profit Ratio | 99.29% | 40.09% | 41.46% | 69.11% | 63.72% | 49.36% | 41.17% | 27.43% | 35.36% | -7,655.56% | 0.00% |
Research & Development | 0.00 | 37.60M | 164.00K | 179.00K | 740.00K | 1.81M | 11.40M | 4.60M | 5.10M | 0.00 | 1.69M |
General & Administrative | 0.00 | 0.00 | 4.50M | 5.50M | 7.39M | 15.49M | 18.28M | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 5.07M | 8.19M | 4.50M | 5.50M | 7.39M | 15.49M | 18.28M | 1.80M | 720.00K | 8.69M | 2.20M |
Other Expenses | 983.00K | 8.68M | -4.50M | 3.02M | 2.94M | 7.96M | 8.37M | 949.00K | 806.00K | 246.00K | 0.00 |
Operating Expenses | 6.06M | 8.68M | -8.00K | 8.53M | 10.33M | 25.26M | 26.65M | 21.04M | 15.65M | 9.10M | 3.07M |
Cost & Expenses | 6.06M | 8.68M | 931.00K | 8.82M | 10.97M | 26.68M | 30.04M | 24.51M | 18.19M | 11.89M | 3.08M |
Interest Income | 1.31M | 196.00K | 94.00K | 58.00K | 104.00K | 12.00K | 34.00K | 17.00K | 35.00K | 5.00K | 166.67K |
Interest Expense | 2.74M | 4.71M | 1.74M | 1.12M | 664.00K | 729.00K | 367.00K | 472.00K | 964.00K | 1.49M | 0.00 |
Depreciation & Amortization | 7.00K | 16.00K | 233.00K | 325.00K | 622.00K | 1.31M | 1.09M | 955.00K | 273.00K | 83.00K | 2.00K |
EBITDA | -11.05M | -42.72M | -14.53M | -12.88M | -14.76M | -23.42M | -52.52M | -18.44M | -17.29M | -11.53M | -2.72M |
EBITDA Ratio | -1,116.46% | -10,931.18% | 4.99% | -827.28% | -570.58% | -838.30% | -499.22% | -430.03% | -473.56% | -34,538.89% | 0.00% |
Operating Income | -5.07M | -46.72M | 48.00K | -8.29M | -11.11M | -26.54M | -29.85M | -19.73M | -14.25M | -11.86M | -2.72M |
Operating Income Ratio | -512.32% | -10,404.90% | 2.99% | -880.15% | -624.69% | -949.79% | -518.12% | -412.93% | -362.05% | -32,933.33% | 0.00% |
Total Other Income/Expenses | -8.73M | -849.00K | -3.23M | -2.44M | -6.14M | -3.88M | -29.15M | 21.00K | -5.85M | 11.21M | -530.67K |
Income Before Tax | -13.80M | -53.89M | -17.13M | -14.96M | -17.24M | -29.14M | -59.00M | -22.03M | -20.10M | -644.00K | -3.25M |
Income Before Tax Ratio | -1,394.04% | -12,002.67% | -1,068.20% | -1,587.58% | -969.80% | -1,043.06% | -1,023.98% | -461.00% | -510.57% | -1,788.89% | 0.00% |
Income Tax Expense | -147.00K | 4.00M | 617.00K | 1.82M | -31.00K | -1.94M | -6.44M | -2.73M | -80.00K | 84.00K | -104.67K |
Net Income | -10.84M | -57.90M | -17.75M | -16.77M | -17.21M | -27.21M | -52.56M | -17.20M | -17.96M | 1.72M | -3.14M |
Net Income Ratio | -1,094.95% | -12,894.43% | -1,106.67% | -1,780.36% | -968.05% | -973.80% | -912.22% | -359.82% | -456.29% | 4,786.11% | 0.00% |
EPS | -0.82 | -4.39 | -1.35 | -1.27 | -1.36 | -2.53 | -5.18 | -1.79 | -2.26 | 0.29 | -2.45 |
EPS Diluted | -0.82 | -4.39 | -1.35 | -1.27 | -1.36 | -2.53 | -5.17 | -1.78 | -2.25 | 0.29 | -2.45 |
Weighted Avg Shares Out | 13.17M | 13.17M | 13.17M | 13.17M | 12.66M | 10.75M | 10.15M | 9.60M | 7.94M | 6.03M | 1.28M |
Weighted Avg Shares Out (Dil) | 13.17M | 13.17M | 13.17M | 13.17M | 12.66M | 10.75M | 10.16M | 9.66M | 7.98M | 6.03M | 1.28M |
Source: https://incomestatements.info
Category: Stock Reports